3 months ago
LLY
AnalystsLouise ChenLouise Chen's Stock Forecasts
AnalystsLouise Chen
Analyst Ranking
Top 16%
#701 out of 4563 analysts
Average Return
+3.59%
Win Rate
46%81 out of 178
Risk vs Reward
Poor
Good
Louise Chen's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Ambrx Biopharma IncAMAM | +233.33% | $8.40 | $28.00 | 2023-10-23 - 2024-03-06 | Strong Buy |
Gracell Biotechnologies IncGRCL | +219.31% | $3.21 | $10.25 | 2023-09-05 - 2024-02-21 | Strong Buy |
Gracell Biotechnologies IncGRCL | +188.73% | $3.55 | $10.25 | 2023-08-30 - 2024-02-21 | Strong Buy |
Soliton IncSOLY | +173.71% | $8.14 | $22.28 | 2020-07-15 - 2021-05-13 | Strong Buy |
Ambrx Biopharma IncAMAM | +173.17% | $10.25 | $28.00 | 2023-09-18 - 2024-03-06 | Strong Buy |
Louise Chen Analyst Color
Get additional color on Louise Chen's coverage of popular stocks
10 months ago
LLY
a year ago
LLY
a year ago
MRK
Louise Chen's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pfizer IncPFE | 18 | Strong Buy | $45.00 | +71.30% | Reiterates | 8 days ago |
Novo Nordisk A SNVO | 10 | Strong Buy | $160.00 | +26.82% | Reiterates | 8 days ago |
Merck & Co IncMRK | 19 | Strong Buy | $135.00 | +6.30% | Reiterates | 8 days ago |
Eli Lilly & CoLLY | 27 | Strong Buy | $815.00 | +11.31% | Reiterates | 8 days ago |
Johnson & JohnsonJNJ | 24 | Strong Buy | $215.00 | +44.75% | Reiterates | 9 days ago |
Regeneron Pharmaceuticals IncREGN | 1 | Hold | $925.00 | +2.04% | Reiterates | 11 days ago |
Rocket Pharmaceuticals IncRCKT | 1 | Strong Buy | $65.00 | +175.07% | Reiterates | 3 months ago |
Adlai Nortye LtdANL | 1 | Strong Buy | $30.00 | +121.40% | Initiates Coverage On | 6 months ago |
Ambrx Biopharma IncAMAM | 4 | Strong Buy | $25.00 | -10.71% | Reiterates | 6 months ago |
Immunovant IncIMVT | 5 | Strong Buy | $45.00 | +56.25% | Maintains | 6 months ago |
Zai Lab LtdZLAB | 3 | Strong Buy | $70.00 | +347.00% | Reiterates | 7 months ago |
Aclaris Therapeutics IncACRS | 3 | Strong Buy | $38.00 | +3,147.86% | Reiterates | 7 months ago |
Mesoblast LtdMESO | 3 | Strong Buy | $68.00 | +993.25% | Reiterates | 7 months ago |
Roivant Sciences LtdROIV | 6 | Strong Buy | $15.00 | +37.61% | Reiterates | 7 months ago |
Connect Biopharma Holdings LtdCNTB | 2 | Strong Buy | $5.00 | +264.96% | Reiterates | 7 months ago |
Atossa Therapeutics IncATOS | 1 | Strong Buy | $5.00 | +233.33% | Initiates Coverage On | 8 months ago |
I MabIMAB | 4 | Strong Buy | $25.00 | +1,281.22% | Reiterates | 8 months ago |
Hutchmed LtdHCM | 2 | Strong Buy | $50.00 | +171.59% | Reiterates | 8 months ago |
Gracell Biotechnologies IncGRCL | 3 | Strong Buy | $20.00 | +95.12% | Reiterates | 8 months ago |
Ardelyx IncARDX | 3 | Strong Buy | $10.00 | +55.52% | Upgrades | 8 months ago |
Vaxcyte IncPCVX | 3 | Strong Buy | $70.00 | +16.09% | Reiterates | 8 months ago |
Arcutis Biotherapeutics IncARQT | 3 | Strong Buy | $50.00 | +471.43% | Reiterates | 8 months ago |
Aravive IncARAV | 7 | Hold | $0.25 | +525.00% | Downgrades | 8 months ago |
Therapeuticsmd IncTXMD | 4 | Hold | $5.00 | +160.42% | Reiterates | 8 months ago |
Scynexis IncSCYX | 2 | Strong Buy | $15.00 | +900.00% | Reiterates | 8 months ago |
Cidara Therapeutics IncCDTX | 2 | Strong Buy | $100.00 | +713.67% | Reiterates | 9 months ago |
Vyne Therapeutics IncVYNE | 1 | Strong Buy | $9.00 | +250.19% | Maintains | a year ago |
Cutera IncCUTR | 3 | Hold | $21.00 | +971.43% | Maintains | a year ago |
Humanigen IncHGENQ | 3 | Hold | $0.15 | N/A | Reinstates | a year ago |
Contrafect CorpCFRXQ | 2 | Hold | $80.00 | N/A | Downgrades | 2 years ago |
Lyra Therapeutics IncLYRA | 1 | Strong Buy | $15.00 | N/A | Initiates Coverage On | 2 years ago |
Spero Therapeutics IncSPRO | 1 | Strong Buy | $5.00 | N/A | Maintains | 2 years ago |
Entasis Therapeutics Holdings IncETTX | 2 | Hold | $2.00 | N/A | Downgrades | 2 years ago |
Rvl Pharmaceuticals PLCRVLPQ | 1 | Strong Buy | $6.00 | N/A | Initiates Coverage On | 3 years ago |
Clarus Therapeutics Holdings IncCRXTQ | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 3 years ago |
Effector Therapeutics IncEFTR | 1 | Strong Buy | $1,250.00 | N/A | Initiates Coverage On | 3 years ago |
Jaguar Health IncJAGX | 1 | Strong Buy | $1,125.00 | N/A | Initiates Coverage On | 3 years ago |
Pds Biotechnology CorpPDSB | 1 | Strong Buy | $25.00 | N/A | Initiates Coverage On | 3 years ago |
Avalo Therapeutics IncAVTX | 1 | Strong Buy | $7.00 | N/A | Initiates Coverage On | 3 years ago |
Soliton IncSOLY | 2 | Hold | $22.60 | N/A | Downgrades | 3 years ago |
Factset Research Systems IncFDS | 1 | Hold | $258.00 | N/A | Maintains | 4 years ago |
Teva Pharmaceutical Industries LtdTEVA | 2 | Hold | $15.00 | N/A | Maintains | 4 years ago |
Endo International PLCENDPQ | 2 | Hold | $18.00 | N/A | Maintains | 6 years ago |
Heron Therapeutics IncHRTX | 1 | Strong Buy | $50.00 | N/A | Maintains | 6 years ago |
Evolus IncEOLS | 1 | Strong Buy | $35.00 | N/A | Maintains | 6 years ago |
Allergan PLCAGN | 1 | Hold | $180.00 | N/A | Maintains | 6 years ago |
Impax Laboratories IncIPXL | 2 | Strong Buy | $35.00 | N/A | Maintains | 6 years ago |
Paratek Pharmaceuticals IncPRTK | 1 | Strong Buy | $44.00 | N/A | Initiates Coverage On | 7 years ago |
Opko Health IncOPK | 2 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 7 years ago |
Neos Therapeutics IncNEOS | 1 | Strong Buy | $20.00 | N/A | Initiates Coverage On | 7 years ago |
Revance Therapeutics IncRVNC | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 7 years ago |
Dermira IncDERM2 | 1 | Strong Buy | $45.00 | N/A | Initiates Coverage On | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.